Vinati Organics Limited (524200) Earnings Call Transcripts
Vinati Organics Limited's Latest Earnings Call - Q4 FY2026
In Q4 FY '26, Vinati Organics Limited reported a net income of INR 624 crores, up 16% quarter-over-quarter, with EBITDA growth of 15% to INR 191 crores. The company maintained stable full-year net income at INR 2,280 crores but saw EBITDA increase by 13% to INR 707 crores. Management expects volume growth of approximately 15% to 20% in FY '27, driven by recovery in demand and new product launches, which could positively impact stock performance.
Reported metrics
| Metric | Value |
|---|---|
| Q4 Net Income | INR 624 crores (beat) |
| Q4 EBITDA | INR 191 crores (beat) |
| FY '26 Net Income | INR 2,280 crores (inline) |
| FY '26 EBITDA | INR 707 crores (beat) |
| FY '26 PAT | INR 444 crores (beat) |
| CapEx for FY '27 | INR 200 to 250 crores (null) |
Guidance from management
Management expects approximately 15% to 20% volume growth in FY '27, supported by new product launches and market recovery. CapEx is projected at INR 200 to 250 crores for ongoing expansion efforts.
What management said
Yes. So some of the projects -- products that are under implementation, most of them are downstream processes as in downstream integration for our products, value-added products. They will be entering to segments such as the fragrance industry, such as personal care, antioxidants in the food additives business -- but most of them, I think what's important there niche chemicals. We are targeting the niche chemicals go...
If I go in the breakup in the percentage terms, you can say 1/3 approximately is attributable to the EDS and you can say in that range, on 15% to 20% is in the form of antioxidants a 10% to 12% in the form of AB, 10 to 12 in IVB and test others that you can say that customize and other products.
What analysts pressed on
Analysts expressed concerns regarding the impact of geopolitical events on raw material availability and the overall market demand. There were questions about the company's capacity utilization and future pricing strategies amid market fluctuations.
Main topics on the call
- Revenue Growth — Vinati reported a Q4 FY '26 net income of INR 624 crores, a 16% increase from the previous quarter. Management noted, 'We expect approximately 15% to 20% volume growth in FY '27.'
- EBITDA Performance — EBITDA for Q4 FY '26 grew by 15% to INR 191 crores. The full-year EBITDA increased by 13% to INR 707 crores, indicating strong operational efficiency.
- CapEx Plans — The company plans to invest INR 200 to 250 crores in CapEx for FY '27, focusing on capacity expansion and new product development. Management stated, 'We successfully completed our ETS capacity expansion during the year....
- Product Segmentation and Growth — The customized products segment recorded a 10% year-on-year growth, while the antioxidant business grew by 15%. Management expects this momentum to continue into FY '27.
Read the full Vinati Organics Limited transcript (Q4 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About Vinati Organics Limited
Vinati Organics Limited (524200) is a publicly listed company in the Chemicals industry, within the Materials sector. It trades on BSE and is based in IN. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 4 calls on record spanning August 18, 2025 to May 27, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 4 Vinati Organics Limited earnings call transcripts on record, spanning August 18, 2025 to May 27, 2026. Based on this history, Vinati Organics Limited reports quarterly. The most recent call on file is dated May 27, 2026. The full list is below — each row opens the complete, free-to-read transcript.
| Quarter | Date | |
|---|---|---|
| Q4 FY2026 | May 27, 2026 | Read transcript → |
| Q4 FY2026 | May 14, 2026 | Read transcript → |
| Q2 FY2026 | Nov 19, 2025 | Read transcript → |
| Special Calls | Aug 18, 2025 | Read transcript → |